Tag: Flaura

EU approves first-line use of AZ’ Tagrisso in lung cancer

by Selina McKee | Jun 11, 2018 | News | 0

AstraZeneca’s Tagrisso has been given a green light in Europe for first-line use to treat EGFR-mutated non-small cell lung cancer (NSCLC), offering a new line of attack at this stage of the disease.

AZ’ Tagrisso offers sustained benefit in lung cancer

by Selina McKee | Apr 16, 2018 | News | 0

AstraZeneca says that the “unprecedented progression-free survival benefit” of Tagrisso when used as a first line treatment for lung cancer is sustained through subsequent lines of therapy.